The Week In... Pharma (21-25/10)
  • Posted on: 25/10/2019
  • Category: Industry

The Week In... Pharma (21-25/10)

GSK agrees to divest rabies and tick-borne encephalitis vaccines, there’s further research into personalised breast cancer treatment, the finalists for the PT Sales Awards are revealed, and search results suggest consumers are at risk of buying fake pharma products online. 

Interested in Star’s innovative outsourcing and resourcing solutions? 

Contact Operations Director, Mark Ward, on 07872 105 540 or email 

On the hunt for a new role, or just curious? 

Visit our candidate page, submit your CV to, or give our offices a ring! 

Consumers at risk of buying fake pharmaceutical products

60% of online search results for pharmaceutical drug leads to fakes putting consumers at risk of buying fake pharmaceutical products.

Finalists announced for the (PT) 2019 Sales Awards

The finalists for the 2019 Sales Awards have now done all they can in their bid to be crowned a coveted winner.

The breast cancer ‘avatar’ mice that could help personalise treatment

Dr Jean Abraham co-leads the Personalised Breast Cancer Programme, a collaboration between Cancer Research UK and Addenbrooke’s Charitable Trust. It has analysed the genes of 600 breast cancer patients to see if they could do this quickly enough to use the information to guide treatment decisions. 

GSK agrees to divest rabies and tick-borne encephalitis vaccines to Bavarian Nordic

GlaxoSmithKline plc announces the divestment of travel vaccines Rabipur for the prevention of rabies, and Encepur for the prevention of tick-borne encephalitis, to Bavarian Nordic.

UK signs medicine logistics deals to mitigate Brexit fallout

UK government signs freight capacity contracts to mitigate the risk that trade disruption will stop medicines from reaching patients related to a potential no-deal Brexit.

While you’re here…

…and are interested in our content, why not sign up to our newsletter?

It’s just below here.